• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAnnexin Pharmaceuticals AB (publ)
    Picture of Annexin Pharmaceuticals AB (publ) logo

    ANNX — Annexin Pharmaceuticals AB (publ) Share News

    SEK7.740.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      SEK55.46m
    • Enterprise Value
      SEK50.19m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ANNX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ANNX Dividends
    • Brief: Annexin Pharmaceuticals Q1 Net Loss Narrows To SEK 5.5 Mln

      02/05/2019 07:35
    • Brief: Annexin Pharmaceuticals Q4 Net Loss Narrows To SEK 7.3 Mln

      31/01/2019 07:29
    • Brief: Annexin Pharmaceuticals Names Henrik Palm New CFO

      21/12/2018 08:36
    • Brief: Annexin Pharmaceuticals Q3 Net Loss Widens To SEK 4.8 Million

      31/10/2018 07:32
    • Brief: Annexin Pharmaceuticals Q2 Operating Loss Narrows To SEK 7.7 Million

      20/08/2018 07:35
    • Brief: Annexin Pharmaceuticals Gets Sek 52 Million In Issue Payment

      22/05/2018 07:24
    • Brief: Annexin Pharmaceuticals Q1 Net Loss Widens To SEK 9.0 Million

      24/04/2018 14:04
    • Brief: Annexin Pharmaceuticals CFO To Leave Company

      27/02/2018 07:30
    • Brief: Annexin Pharmaceuticals Q4 Net Loss Widens To SEK 9.6 Mln

      31/01/2018 14:01
    • Brief: Annexin Pharmaceuticals Q3 net loss at SEK 3.8 mln

      31/10/2017 14:02
    • Brief: Annexin Pharmaceuticals appoints Jamal El-Mosleh new CEO

      11/10/2017 08:16
    • Brief: Annexin Pharmaceuticals Q2 net loss at SEK 10.1 million

      16/08/2017 14:00
    • Brief: Annexin Pharmaceuticals patent approved in the United States

      20/06/2017 07:33
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.